WillItSurvive
AI companies and labs · United States

Hippocratic AI

AI voice agents that handle patient calls, intake, and follow-up for hospitals.

Protection under test
Assessed 20 July 2026 · Evidence as of 20 July 2026
Something worth protecting exists and is being tested right now.
On the recordSince 20 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: Epic's annual Users Group Meeting where Dragon Copilot roadmap updates typically surface
The call

Hippocratic has real clinical validation and data most rivals lack, but Epic sits on the patient record Hippocratic needs to reach, and its safety numbers are still self-reported.

Hippocratic AI builds software that talks to patients by phone or voice on behalf of doctors and hospitals. It claims an advantage because it has collected data from 180 million patient conversations, trained 7,500 doctors to validate its answers, and obtained special healthcare security approval. This makes it harder for big companies like Epic (which runs most hospital computer systems) or AI labs like OpenAI to quickly build something similar, since they would need the same medical training and approval. The biggest question is whether Epic and Microsoft will build their own patient-facing voice system to compete directly, since they already partner together and Epic already controls the computer system that most hospitals use.

Why
01
AI pressure: OpenAI, Google, Anthropic frontier models. These labs could commoditize the voice layer, but Hippocratic uses their models as ingredients while owning the clinical validation on top. Could AI do the core job? Unlikely.
02
Bigger players: Epic, via its Microsoft/Nuance Dragon Copilot partnership. Epic owns the patient record and Dragon Copilot already does clinician documentation; extending it to patient-facing calls would cut Hippocratic out. Could a giant copy it? Probably.
03
What protects it. HITRUST certification, a 7,500-clinician validation network, and multi-year health-system integrations that took years to build and are hard to copy fast.
What would change this call
Epic or Microsoft ships a patient-facing voice agent for intake or follow-up beyond ambient scribing. Would show the EHR incumbent is entering Hippocratic's core workflow directly.
An independent audit of Hippocratic's 99.9% safety or 0.00% severe-harm claims is published. Would confirm or contradict self-reported safety metrics underpinning the trust moat.
A state regulator mandates human-in-the-loop oversight for automated patient-voice workflows. Would show nursing-union pressure translating into binding restrictions on deployment.
Key numbers
  • $126M Series C at $3.5B valuation (2025-11-03)
  • 180-200M+ patient interactions logged (2026-04)
  • 50+ health-system partners named (2026-01-13)
Named risks
  • Unaudited self-reported safety metrics (99.9% accuracy, 0.00% severe harm) could be contradicted by independent audit. Severity: high
  • Epic/Microsoft Dragon Copilot could extend into patient-facing voice, squeezing independent vendors. Severity: high
  • Nursing union opposition could trigger state-level regulation mandating human-in-the-loop workflows. Severity: medium
  • No exclusive contracts with health systems mean integrations could be displaced by rivals. Severity: medium
  • Single high-profile patient harm incident could severely damage trust and adoption. Severity: high
Rivals, as read in July 2026
RivalDirectionEvidence
Epic and Microsoft (Dragon Copilot)contestingEpic selected Microsoft for native ambient documentation, announced late summer 2025
Abridge, Ambience Healthcare, Suki AI, NablacontestingNamed the 'Big 4' ambient AI rivals by MedCity News, November 14, 2025
National Nurses United (labor opposition)losing to20+ hospital demonstrations against AI nurse deployment as of March 2025
Sierra AI (Bret Taylor)contestingHealthcare-agnostic voice-agent peer identified as competitor, June 2026
Hyro.ai, Sully AI, Notable Health, Infinitus, Lindy AI, Luma HealthcontestingListed as front-desk and patient-engagement AI alternatives, July 2026
Questions people ask
Is Hippocratic AI profitable?
No audited revenue or profitability figures are public. A third-party aggregator (Datanyze) estimates revenue around $50M, but this is unverified and methodology is unclear. The company raised $126M in Series C funding on November 3, 2025 at a $3.5B valuation, suggesting continued reliance on venture capital rather than profits.
Could AI replace Hippocratic AI's own product?
Hippocratic AI's moat rests on proprietary clinical data from 180 to 200 million patient interactions, HITRUST e1 certification, and a 7,500 clinician validation network, as of April 2026. Generic frontier models like GPT or Gemini lack this liability and validation layer, though Epic and Microsoft's Dragon Copilot pose a credible platform threat.
Who is Hippocratic AI's biggest competitor?
Epic, via its Microsoft-powered Dragon Copilot partnership announced in late summer 2025, is the most structurally dangerous threat since Epic owns the EHR system of record. Direct rivals in ambient clinical AI include Abridge, Ambience Healthcare, Suki AI, and Nabla, dubbed the 'Big 4' by MedCity News in November 2025.
Who owns Hippocratic AI?
Hippocratic AI is a privately held, venture-backed startup with no parent company, led by CEO and co-founder Munjal Shah. Its $126M Series C, closed November 3, 2025 at a $3.5B valuation, was led by Avenir Growth with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, and hospital-system investor UHS.
Are nurses being replaced by Hippocratic AI?
Hippocratic AI builds voice agents restricted to non-diagnostic tasks like intake, scheduling, and chronic-care follow-up, not prescribing or diagnosing, per its November 2025 Series C announcement. National Nurses United has organized over 20 hospital demonstrations against the technology, citing safety and worker displacement concerns, ongoing as of March 2025 reporting.
How much funding has Hippocratic AI raised in total?
Hippocratic AI has raised $404M total as of November 3, 2025, across seed ($50M, May 2023), Series A ($53M at $500M valuation, March 2024), Series B ($141M at $1.64B valuation, January 9, 2025), and Series C ($126M at $3.5B valuation, November 3, 2025).
Timeline
  • 2026-05-20Expanded life sciences leadership team amid pharma and medtech demand growth
  • 2026-04-16Launched AI Front Door and Nurse Co-Pilot products, plus Polaris 5.0 model
  • 2026-01-13Announced expansion across healthcare verticals with 50+ partners disclosed
  • 2026-01-12Acquired Grove AI, launched Life Sciences Division, partnered with BCG
  • 2025-11-14Epic/Microsoft Dragon Copilot ambient AI partnership coverage noted as threat
  • 2025-11-03Closed $126M Series C at $3.5B valuation led by Avenir Growth
  • 2025-03-16AP reports nursing union pushback and 20+ hospital demonstrations against AI nurses
  • 2025-01-10Launched Healthcare AI Agent App Store for clinicians
  • 2025-01-09Completed $141M Series B at $1.64B valuation led by Kleiner Perkins
  • 2024-03Raised $53M Series A at $500M valuation co-led by Premji Invest and General Catalyst
Revision history
20 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources